Sectoral Asset Management Inc Ptc Therapeutics, Inc. Transaction History

Sectoral Asset Management Inc

$120 Million
Q3 2024

A detailed history of Sectoral Asset Management Inc transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Sectoral Asset Management Inc holds 7,600 shares of PTCT stock, worth $347,852. This represents 0.23% of its overall portfolio holdings.

Number of Shares

7,600

Previous 4,300 76.74%

Holding current value

$347,852

Previous $131,000 114.5%

% of portfolio

0.23%

Previous 0.07%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$30.39 - $37.66 $100,287 - $124,277	3,300 Added 76.74%	7,600 $281,000
Q2 2024 Aug 13, 2024	BUY	$24.69 - $40.12 $106,167 - $172,516	4,300 New	4,300 $131,000
Q3 2023 Nov 14, 2023	SELL	$22.41 - $41.99 $1 Million - $1.88 Million	-44,680 Reduced 19.28%	187,016 $4.19 Million
Q2 2023 Aug 11, 2023	BUY	$40.4 - $59.1 $207,252 - $303,183	5,130 Added 2.26%	231,696 $9.42 Million
Q1 2023 May 12, 2023	SELL	$38.16 - $48.86 $35,298 - $45,195	-925 Reduced 0.41%	226,566 $11 Million
Q4 2022 Feb 10, 2023	SELL	$33.53 - $54.79 $382,242 - $624,606	-11,400 Reduced 4.77%	227,491 $8.68 Million
Q3 2022 Nov 10, 2022	SELL	$41.85 - $53.85 $42,561 - $54,765	-1,017 Reduced 0.42%	238,891 $12 Million
Q2 2022 Aug 15, 2022	SELL	$25.6 - $45.23 $626,764 - $1.11 Million	-24,483 Reduced 9.26%	239,908 $9.61 Million
Q1 2022 May 10, 2022	BUY	$33.33 - $44.6 $69,993 - $93,660	2,100 Added 0.8%	264,391 $9.86 Million
Q4 2021 Feb 11, 2022	BUY	$35.36 - $41.86 $353,600 - $418,600	10,000 Added 3.96%	262,291 $10.4 Million
Q3 2021 Nov 15, 2021	SELL	$37.01 - $44.74 $2.96 Million - $3.58 Million	-80,000 Reduced 24.08%	252,291 $9.39 Million
Q2 2021 Aug 16, 2021	SELL	$37.95 - $49.37 $6.55 Million - $8.52 Million	-172,637 Reduced 34.19%	332,291 $14 Million
Q1 2021 May 14, 2021	SELL	$46.8 - $68.92 $4.64 Million - $6.83 Million	-99,050 Reduced 16.4%	504,928 $23.9 Million
Q4 2020 Feb 12, 2021	SELL	$47.96 - $67.64 $3.15 Million - $4.44 Million	-65,600 Reduced 9.8%	603,978 $36.9 Million
Q3 2020 Nov 13, 2020	BUY	$45.41 - $57.07 $6.76 Million - $8.5 Million	148,911 Added 28.6%	669,578 $31.3 Million
Q2 2020 Aug 13, 2020	BUY	$42.56 - $54.98 $9.44 Million - $12.2 Million	221,823 Added 74.23%	520,667 $26.4 Million
Q1 2020 May 13, 2020	SELL	$32.37 - $59.36 $967,668 - $1.77 Million	-29,894 Reduced 9.09%	298,844 $13.3 Million
Q4 2019 Feb 12, 2020	SELL	$32.22 - $50.07 $1.56 Million - $2.43 Million	-48,500 Reduced 12.86%	328,738 $15.8 Million
Q3 2019 Nov 14, 2019	SELL	$33.82 - $48.17 $2.48 Million - $3.54 Million	-73,400 Reduced 16.29%	377,238 $12.8 Million
Q2 2019 Aug 14, 2019	SELL	$35.42 - $45.0 $442,714 - $562,455	-12,499 Reduced 2.7%	450,638 $20.3 Million
Q1 2019 May 14, 2019	BUY	$28.09 - $39.49 $6.45 Million - $9.07 Million	229,601 Added 98.32%	463,137 $17.4 Million
Q4 2018 Feb 12, 2019	BUY	$29.83 - $46.51 $873,989 - $1.36 Million	29,299 Added 14.35%	233,536 $8.02 Million
Q3 2018 Nov 14, 2018	BUY	$33.9 - $47.77 $2.32 Million - $3.27 Million	68,353 Added 50.3%	204,237 $9.6 Million
Q2 2018 Aug 13, 2018	SELL	$25.7 - $47.88 $7.76 Million - $14.5 Million	-302,050 Reduced 68.97%	135,884 $4.58 Million
Q1 2018 May 15, 2018	BUY	$17.46 - $32.59 $1.14 Million - $2.13 Million	65,300 Added 17.52%	437,934 $11.9 Million
Q4 2017 Feb 13, 2018	BUY	$15.14 - $20.89 $3.06 Million - $4.22 Million	202,099 Added 118.51%	372,634 $6.22 Million
Q3 2017 Nov 14, 2017	BUY	$16.81 - $21.61 $2.87 Million - $3.69 Million	170,535	170,535 $3.41 Million

Others Institutions Holding PTCT

# of Institutions

221

Shares Held

78.1M

Call Options Held

144K

Put Options Held

58.7K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.27B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.

Account

Sectoral Asset Management Inc Ptc Therapeutics, Inc. Transaction History